Provectus Pharmaceuticals (PVCT) just unveiled an announcement.
Bruce Horowitz has stepped down from his roles at Provectus Biopharmaceuticals, including his position on the Board and as Chief Operating Officer. A termination agreement was reached, wherein Horowitz will receive a total payment of $508,000 if paid by June 30, 2024, and he has agreed to a five-year standstill on company securities. Following his departure, the company has appointed Dominic Rodrigues as the chief operations consultant and principal executive officer. Rodrigues brings a wealth of experience from various industries and academia, and will receive a monthly payment of $20,000 for his services, with the contract operating on a month-to-month basis.
For an in-depth examination of PVCT stock, go to TipRanks’ Stock Analysis page.
